Assuming Eli Lilly follows a similar timeline to tirzepatide, the earliest possible FDA approval for retatrutide would likely occur in late 2027 or 2028, depending on Phase 3 trial results and regulatory review timelines
Neuroprotection & cognitive function investigations
Even though developing a vaccine against GPNMB positive cells seems to be beneficial, the challenge remains to only deplete cells with the highest expression of the protein but not the cells expressing it at a physiological level 63
Cyanocobalamin has many approved indications (many that lead to a deficiency of cyanocobalamin through an impairment of absorption of cyanocobalamin) including: Cyanocobalamin can be administered via intramuscular (IM) or subcutaneous (SC) routes
Texas: Austin, Dallas, Fort Worth, Houston, New Braunfels, San Antonio
Individual responses to B-12 injections vary